Cargando…

Comparison between 0.1% Nepafenac and 1% Prednisolone Eye Drop in Postoperative Management Following Micro-incisional Cataract Surgery

PURPOSE: To compare the efficacy of 0.1% nepafenac and 1% prednisolone acetate eye drop in postoperative inflammation control in micro-incisional cataract surgery. METHODS: We conducted a prospective, randomized, comparative, single-blind study. All the patients underwent temporal 2.2-mm micro-incis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sarkar, Sandip, Bardoloi, Narayan, Deb, Amit Kumar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Ophthalmological Society 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8200587/ https://www.ncbi.nlm.nih.gov/pubmed/34120417 http://dx.doi.org/10.3341/kjo.2020.0135

Ejemplares similares

Comparison of once daily dose of 0.3% nepafenac alone and three times dose of 0.1% nepafenac alone in pain and inflammation control after phacoemulsification
por: Bardoloi, Narayan, et al.
Publicado: (2022)

Analgesic and anti-inflammatory effectiveness of nepafenac 0.1% for cataract surgery
por: Nardi, M, et al.
Publicado: (2007)

Topical nepafenac 0.1% alone versus prednisolone acetate 1% as postoperative anti-inflammatory agents in small gauge vitrectomy
por: Nagpal, Manish, et al.
Publicado: (2014)

Comparison of preoperative nepafenac (0.1%) and flurbiprofen (0.03%) eye drops in maintaining mydriasis during small incision cataract surgery in patients with senile cataract: A randomized, double-blind study
por: Sarkar, Saumya, et al.
Publicado: (2015)

Eyelid excoriation and erythema with nepafenac eye drop
por: Saurabh, Kumar, et al.
Publicado: (2016)

Capsular tension ring assisted phacoemulsification of morgagnian cataract
por: Bardoloi, Narayan, et al.
Publicado: (2021)

Comparison of the efficacy of Diclofenac 0.1% and Nepafenac 0.1% on anterior chamber cells in patients undergoing cataract surgery: A prospective clinical practice trial
por: Ahmad, Adnan, et al.
Publicado: (2023)

Phase II placebo-controlled study of nepafenac ophthalmic suspension 0.1% for postoperative inflammation and ocular pain associated with cataract surgery in Japanese patients
por: Numaga, Jiro
Publicado: (2011)

Zero Phaco: A new technique for dealing with soft cataracts
por: Bardoloi, Narayan, et al.
Publicado: (2022)

Efficacy and safety of dropless cataract surgery
por: Bardoloi, Narayan, et al.
Publicado: (2020)

Treatment of cystoid macular edema with the new-generation NSAID nepafenac 0.1%
por: Hariprasad, Seenu M, et al.
Publicado: (2009)

Nepafenac-Loaded Cyclodextrin/Polymer Nanoaggregates: A New Approach to Eye Drop Formulation
por: Lorenzo-Veiga, Blanca, et al.
Publicado: (2019)

Phacoemulsification without hydroprocedure: A novel technique to deal with posterior polar cataracts
por: Bardoloi, Narayan, et al.
Publicado: (2022)

Efficacy of nepafenac ophthalmic suspension 0.1% in improving clinical outcomes following cataract surgery in patients with diabetes: an analysis of two randomized studies
por: Singh, Rishi P, et al.
Publicado: (2017)

Evaluation effectiveness of 0.1% nepafenac on injection-related pain in patients undergoing intravitreal Ozurdex injection
por: Ogurel, Tevfik, et al.
Publicado: (2019)

Proficiency of eye drop instillation in postoperative cataract patients in Ghana
por: Liu, Yang, et al.
Publicado: (2013)

Effect of preoperative use of topical prednisolone acetate, ketorolac tromethamine, nepafenac and placebo, on the maintenance of intraoperative mydriasis during cataract surgery: A randomized trial
por: Zanetti, Fernando Roberte, et al.
Publicado: (2012)

Comparison of bromfenac 0.09% QD to nepafenac 0.1% TID after cataract surgery: pilot evaluation of visual acuity, macular volume, and retinal thickness at a single site
por: Cable, Melissa
Publicado: (2012)

Assessment of the eye surface and subjective symptoms after using 0.1% dexamethasone drops with and without preservatives in patients after cataract surgery
por: Muzyka-Woźniak, Maria, et al.
Publicado: (2023)

Efficacy of Topical Nepafenac 0.3% in the Management of Postoperative Cystoid Macular Edema
por: Giarmoukakis, Athanassios K, et al.
Publicado: (2020)

Long-term outcomes of 0.1% tacrolimus eye drops in eyes with severe allergic conjunctival diseases
por: Yazu, Hiroyuki, et al.
Publicado: (2021)

Comparison of 0.1%, 0.18%, and 0.3% Hyaluronic Acid Eye Drops in the Treatment of Experimental Dry Eye
por: You, In Cheon, et al.
Publicado: (2018)

Evaluation of nepafenac in prevention of macular edema following cataract surgery in patients with diabetic retinopathy
por: Singh, Rishi, et al.
Publicado: (2012)

Inhibition of surgically induced miosis and prevention of postoperative macular edema with nepafenac
por: Cervantes-Coste, Guadalupe, et al.
Publicado: (2009)

Changes in pattern electroretinogram after application of 0.01% atropine eye drops
por: Kothari, Mihir, et al.
Publicado: (2019)

Development of prednisolone-containing eye drop formulations by cyclodextrin complexation and antimicrobial, mucoadhesive biopolymer
por: Bíró, Tivadar, et al.
Publicado: (2018)

Combination of 0.05% Azelastine and 0.1% Tacrolimus Eye Drops in Children With Vernal Keratoconjunctivitis: A Prospective Study
por: Chen, Minjie, et al.
Publicado: (2021)

Dexamethasone/Netilmicin Eye Drops and Eye Gel for the Treatment of Ocular Inflammation After Micro-Incisional Vitreoretinal Surgery
por: Rapisarda, Antonio, et al.
Publicado: (2020)

Comments on: Changes in pattern electroretinogram after application of 0.01% atropine eye drops
por: Jethani, Jitendra, et al.
Publicado: (2020)

Topical nepafenac for prevention of post-cataract surgery macular edema in diabetic patients: patient selection and perspectives
por: Yüksel, Bora, et al.
Publicado: (2017)

Commentary: Let us ponder - Choosing between topical Nepafenac and topical steroids after cataract surgery
por: Tripathi, Amruta S
Publicado: (2022)

Effects of preoperative doses of betamethasone acetate 0.1% on dry eye control after cataract surgery
por: Shokoohi-Rad, Saeed, et al.
Publicado: (2020)

Ophthalmic nepafenac use in the Netherlands and Denmark
por: Margulis, Andrea V, et al.
Publicado: (2017)

In Vitro and Ex Vivo Evaluation of Nepafenac-Based Cyclodextrin Microparticles for Treatment of Eye Inflammation
por: Lorenzo-Veiga, Blanca, et al.
Publicado: (2020)

Therapeutic effects of 0.1% tacrolimus eye drops for refractory allergic ocular diseases with proliferative lesion or corneal involvement
por: Fukushima, Atsuki, et al.
Publicado: (2014)

Effect of topical nepafenac in prevention of macular edema after cataract surgery in patients with non-proliferative diabetic retinopathy
por: Sarfraz, Muhammad Haroon, et al.
Publicado: (2017)

Response to comments on: Changes in pattern electroretinogram after application of 0.01% atropine eye drops
por: Kothari, Mihir, et al.
Publicado: (2020)

Erratum: Effects of preoperative doses of betamethasone acetate 0.1% on dry eye control after cataract surgery
Publicado: (2020)

Topical nepafenac in the treatment of diabetic macular edema
por: Callanan, David, et al.
Publicado: (2008)

Effect of low-concentration atropine (0.01%) eye drops on higher-order aberrations in myopic children
por: Jethani, Jitendra, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dfblijg7ujjncq59od98v4cnr8